The information on this page is intended for journalists, press and media. Click YES to get to the newsroom. If you click NO you will come back to Mynewsdesk.com.
EpiGuard is a Norwegian company established in 2015 providing better solutions for safe transportation of contagious patients. Our team of medical experts and engineers developed the EpiShuttle based on analysis and clinical first-hand experience from previous global epidemics. Our medical background ranges from intensive care, infectious diseases, internal medicine and anesthesiology, and transport medicine. EpiShuttle improves patient safety and care, the safety for health care providers, reduce costs and increase operational efficiency. The EpiShuttle is NATOs stock listed and CE-marked as a class one medical device. Through LifePort, the EpiShuttle is registered with both the FDA and Health Canada.
Saving one – protecting everyone.